<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00975910</url>
  </required_header>
  <id_info>
    <org_study_id>20090801</org_study_id>
    <nct_id>NCT00975910</nct_id>
  </id_info>
  <brief_title>Effect of Lidocaine in Antiarrhythmic Dosage on Postoperative Cognitive Dysfunction in Supratentorial Craniotomy Dysfunction in Supratentorial Craniotomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>State University of New York - Downstate Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of lidocaine in antiarrhythmic dosage
      on postoperative cognitive dysfunction in supratentorial craniotomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mini-Mental State Examination (MMSE)</measure>
    <time_frame>Preoperatively, 3 days and 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Montreal Cognitive Assessment (MoCA)</measure>
    <time_frame>Preoperatively, 3 days and 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Hamilton Depression Scale (HAMD)</measure>
    <time_frame>Preoperatively, 3 days and 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Dementia Rating (CDR)</measure>
    <time_frame>Preoperatively, 3 days and 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Confusion Assessment Method for the Diagnosis of Delirium in the Intensive Care unit (ICU) (CAM-ICU)</measure>
    <time_frame>1 day and 3 days postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AjDO2 (Arterial Jugular Difference)</measure>
    <time_frame>Injection of test dosage, 1 hour, 2 hours, 3 hours after injection of test dosage, end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AjDGlc</measure>
    <time_frame>Injection of test dosage, 1 hour, 2 hours, 3 hours after injection of test dosage, end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AjDGlutamate</measure>
    <time_frame>Injection of test dosage, 1 hour, 2 hours, 3 hours after injection of test dosage, end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AjDLct</measure>
    <time_frame>Injection of test dosage, 1 hour, 2 hours, 3 hours after injection of test dosage, end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>S100</measure>
    <time_frame>Injection of test dosage, end of surgery, 24 hours after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amyloid-β protein(Aβ)</measure>
    <time_frame>Injection of test dosage, end of surgery, 24 hours after operation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Supratentorial Craniotomy Dysfunction</condition>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine</intervention_name>
    <description>Lidocaine arm: lidocaine (2%) as an intravenous bolus (1.5 mg/kg) during induction followed by an intravenous infusion (2 mg. kg(-1).h(-1)) after induction until at the end of surgery</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>Saline arm: infused at the same rate as lidocaine</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 years old, ASA physical status I or II, BMI&lt;30

          -  Scheduled for elective supratentorial craniotomy

          -  MMSE&lt;24 before operation

          -  Cooperative and given informed consent in person

        Exclusion Criteria:

          -  History of mental or psychiatric disorders

          -  Contraindicated to internal jugular venous catheterization

          -  Pregnant or lactating female

          -  History of systemic malignant tumor or diabetes

          -  Previously treated with this protocol or participated in another study within previous
             30 days

          -  Suspected history of allergic reaction or intolerance to amides or other anesthetic
             agents in this study

          -  History of alcohol abuse and/or drug abuse within previous one year

          -  History or a family history of malignant hyperthermia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology,Beijing Tiantan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2009</study_first_submitted>
  <study_first_submitted_qc>September 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2009</study_first_posted>
  <last_update_submitted>May 21, 2013</last_update_submitted>
  <last_update_submitted_qc>May 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Wei Zhang</investigator_full_name>
    <investigator_title>attending</investigator_title>
  </responsible_party>
  <keyword>Supratentorial Craniotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

